View Older Stories View More Recent Stories

Jun 18, 2018 05:45AM Cytokinetics (CYTK) Reports Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy
Jun 14, 2018 05:53AM Innovate Biopharma (INNT) Appoints Saira Ramasastry to Board; Announces Resignation of Anna Kazanchyan M.D. from Board
Jun 13, 2018 08:22AM ATARA Biotherapeutics (ATRA) Publishes New Research Linking Epstein-Barr Virus Infection and Multiple Sclerosis
Jun 13, 2018 05:49AM AbbVie (ABBV) Highlights Additional Outcomes Data from Three Upadacitinib Phase 3 Studies in Rheumatoid Arthritis at EULAR 2018
Jun 12, 2018 07:04AM Arcus Biosciences (RCUS) Announces Promotion of Jennifer Jarrett to COO
Jun 12, 2018 05:00AM China Online Education Group Announces First Quarter 2018 Results
Jun 8, 2018 04:01PM Cytokinetics (CYTK) Announces Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy to be Presented at SMA Conf.
Jun 7, 2018 08:10AM ATARA Biotherapeutics (ATRA) Announces Appointment of Utpal Koppikar as CFO
Jun 6, 2018 06:39PM QS World University Rankings 2019: MIT Named World’s Best University for Record-Breaking Seventh Consecutive Year
Jun 5, 2018 05:34PM Deckers Outdoor (DECK) Appoints Two New Independent Directors
Jun 4, 2018 04:21PM eHealth (EHTH) Names Derek N. Yung as Chief Financial Officer
Jun 4, 2018 09:25AM Kilroy Realty (KRC) Reports Acquisition of Life Science Development Site in South San Francisco
Jun 4, 2018 09:05AM Galectin Therapeutics (GALT) Reports Election of Richard E. Uihlein as Board Chairman
Jun 4, 2018 08:05AM Versartis (VSAR) Reports Merger Agreement with Aravive Biologics
Jun 4, 2018 06:26AM Jazz Pharmaceuticals (JAZZ) Announces Long-Term Safety & Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol
Jun 4, 2018 06:24AM Jazz Pharmaceuticals (JAZZ) Reports Long-Term Safety and Efficacy Data for Xyrem (sodium oxybate) in Pediatric Patients
Jun 1, 2018 07:33AM Pfizer (PFE) Reports Positive CHMP Opinion for Oncology Biosimilar, TRAZIMERA (trastuzumab)
May 29, 2018 04:27PM PayPal (PYPL) Acquires Jetlore
May 28, 2018 08:03AM Nike Tennis Camps Returns to Stanford University Summer 2018 Led by Head Coach Lele Forood
May 24, 2018 08:34AM Riot Blockchain (RIOT) Announces Strategic Investment in The Block
May 24, 2018 08:07AM Krystal Biotech (KRYS) Granted FDA Fast Track Designation for KB103 for Treatment of Dystrophic Epidermolysis Bullosa
May 23, 2018 05:55PM Stanford Graduate School of Business Recognizes Students Committed to Social Innovation
May 23, 2018 01:34PM Atlas Air Worldwide Holdings (AAWW) Announces Election of Jane H. Lute and Sheila A. Stamps to Board
May 23, 2018 12:24AM Stanford Self-Made Millionaire Comes to LA to Shoot Documentary
May 21, 2018 05:52PM Form 4 Energy XXI Gulf Coast, For: May 17 Filed by: SPRINGEL STANFORD
May 21, 2018 08:30AM Stanford Researchers Presented Results from an Exploratory Study of Serlopitant for the Treatment of Chronic Itch in Epidermolysis Bullosa Patients Indicating Reduction in Itch with Serlopitant Treatm
May 21, 2018 08:30AM Stanford Researchers Presented Results from an Exploratory Study of Serlopitant for the Treatment of Chronic Itch in Epidermolysis Bullosa Patients Indicating Reduction in Itch with Serlopitant Treatm
May 21, 2018 07:01AM Fibrocell Science (FCSC) Announces Interim Results and Progress of Phase 1/2 Clinical Trial of FCX-007 Gene Therapy
May 17, 2018 11:20AM Stanford Leadership Summer Camp Draws Students from Around the World
May 17, 2018 09:21AM Abeona Therapeutics (ABEO) Updates Clinical Data from Phase 1/2 Trial for EB-101 Gene Therapy in Epidermolysis Bullosa
May 15, 2018 04:51PM Aileron Therapeutics (ALRN) CEO Resigns
May 14, 2018 08:16AM Abeona Therapeutics (ABEO) Announces Appointment of Stefano Buono and Richard Van Duyne to its Board of Directors
May 10, 2018 04:44PM NMI Holdings (NMIH) COO Claudia Merkle Promoted to President
May 10, 2018 09:18AM Krystal Biotech (KRYS) Reports First Patient Dosing in Phase 1/2 trial of KB103
May 10, 2018 07:14AM Rexford Industrial Realty (REXR) Acquires 2 Industrial Properties for $127.1M; Reports Sale of 2 Properties for $9.1M
May 8, 2018 08:10AM Audentes Therapeutics (BOLD) Names Natalie Holles President and COO
May 8, 2018 07:00AM Proteostasis Announces Formation of Independent Steering Committee of Leading Experts to Advise on the Global Phase 3 Clinical Development Program for PTI-428 in Cystic Fibrosis
May 1, 2018 08:36AM Jazz Pharmaceuticals (JAZZ) Reports Supplemental NDA Filling for Xyrem (sodium oxybate)
May 1, 2018 08:11AM Medtronic (MDT) Announces FDA Approval for Deep Brain Stimulation Therapy for Medically Refractory
Apr 30, 2018 04:14PM TransDigm Group (TDG) Names Kevin Stein as President and CEO and W. Nicholas Howley as Executive Chairman
Apr 26, 2018 08:10AM Krystal Biotech (KRYS) Announces FDA Clearance of IND on KB103 to Begin Enrolling Patients for the Treatment of Dystrophic Epidermolysis Bullosa
Apr 25, 2018 08:05AM AveXis (AVXS) Reports First Patient Dosed in Phase 3 Trial of AVXS-101 in Pre-Symptomatic SMA Types 1, 2 and 3
Apr 24, 2018 04:08PM AveXis (AVXS) Presents Initial Data from Pivotal U.S. Trial for SMA Type 1 and 24-Month Follow-Up Data from Phase 1 Trial of AVXS-101 in SMA Type 1
Apr 24, 2018 08:07AM TG Therapeutics (TGTX) Announces Updated Results from Ongoing Phase 2 Study of Ublituximab in Patients with MS at AAN
Apr 24, 2018 08:06AM PolarityTE (COOL) Names Willie Bogan to Board
Apr 19, 2018 04:16PM Rexford Industrial Realty (REXR) Appoints Diana Ingram To Board Of Directors
Apr 13, 2018 09:04AM Stanford University School of Medicine Presents Results of Research Partnership with Gen Nine in Clinical Study of CosmosVue
Apr 12, 2018 04:31PM Cisco Systems (CSCO) Announces Mark Garrett to Board
Apr 9, 2018 08:07AM Natera (NTRA) Names Paul R. Billings, M.D., Ph.D., as Chief Medical Officer
Apr 6, 2018 08:00AM PriceSmart (PSMT) Names Maarten Jager as EVP & CFO
View More Recent Stories View Older Stories